Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 369 results for "Ibrutinib"

Janssen Asks FDA to Approve Imbruvica as 1st Treatment for Marginal Zone Lymphomas
LymphomaNewsToday.com

Janssen seeks US FDA approval for ibrutinib to treat marginal ...

Janssen Research & Development, LLC announced that a supplemental New Drug Application (sNDA) for ibrutinib (Imbruvica) has been submitted to the US Food and Drug Administration (FDA) for the treatment of patients with marginal zone lymphoma (MZL) ... PharmaBiz, 1 day ago
FDA to Review Imbruvica for Rare Lymphoma Indication Renal & Urology News, 3 days ago
IMBRUVICA® sNDA Submitted to the FDA for Marginal Zone Lymphoma (MZL) American Pharmaceutical Review, 3 days ago

22 images for Ibrutinib

Cancer Therapy Advisor, 2 days ago
Cancer Therapy Advisor, 6 days ago
Cancer Therapy Advisor, 2 weeks ago
Irish Examiner, 1 month ago
CPhI.cn, 2 months ago
Targeted Oncology, 3 months ago
Pharmafile, 3 months ago
Cancer Therapy Advisor, 3 months ago
Nasdaq, 3 months ago
Pharmafile, 4 months ago
Cancer Therapy Advisor

Ibrutinib Linked With Favorable Survival, High Response Rate in CLL

Share this content: Treatment with ibrutinib may be associated with favorable progression-free and overall survival as well as high overall response rate. Treatment with ibrutinib may be associated with favorable progression-free and overall ...
 Cancer Therapy Advisor6 days ago Ibrutinib Active in Patients With R/R CLL and 17p Deletion  Cancer Therapy Advisor2 weeks ago Anticancer drug does not appear to block flu vaccine response in patients with chronic lymphocytic leukemia  National Heart Lung and Blood Institute1 month ago Ibrutinib Does Not Block Flu Vaccine Response in CLL Patients  General Medicine eJournal1 month ago

Clinical Trial: TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The article below represents a preview only and is not meant for reuse or republishing. U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT02874404) titled 'TGR-1202 and Ibrutinib in Treating Patients With ...
 HT Syndication1 month ago

Pending EC decision: Imbruvica, ibrutinib, Opinion date: 21-Jul-2016

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Imbruvica. The marketing authorisation holder for this medicinal product ...
 European Medicines Agency2 months ago

Janssen Pharmaceutical Companies Release: Ibrutinib (IMBRUVICA) Supplemental New Drug Application Submitted To The FDA For Marginal Zone Lymphoma (MZL)

RARITAN, N.J. , Sept. 26, 2016 /PRNewswire/ --Janssen Research & Development, LLC announced today that a supplemental New Drug Application (sNDA) for ibrutinib (IMBRUVICA ® ) has been submitted to the U.S. Food and Drug Administration (FDA) for the ...
 BioSpace3 days ago Ibrutinib (IMBRUVICA®) Supplemental New Drug Application Submitted to the U.S. Food and Drug Administration (FDA) for Marginal Zone Lymphoma (MZL)  BioSpace3 days ago AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA ®) for Treatment of Marginal Zone Lymphoma  Stockwatch3 days ago 9/26/16 - AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA®) for Treatment of Marginal Zone Lymphoma  Pharmacy Choice3 days ago
[x]  

Forum Post: RE: Ibrutinib/Imbruvica?

Suggest you post this question on the CLLSA, Chronic Lymphocytic Leukaemia pages of Health Unlocked. CLLSA is the Chronic Lymphocytic Support Association of the UK. Just Google Health Unlocked. There you will find many others in your exact ...
 Macmillan Cancer Support2 weeks ago Forum Post: Ibrutinib/Imbruvica?  Macmillan Cancer Support2 weeks ago Health Canada Approves IMBRUVICA® (ibrutinib) for First-line Treatment of Chronic Lymphocytic Leukemia  Yahoo! Canada2 months ago Janssen receives Health Canada approval for Imbruvica to treat chronic lymphocytic leukaemia  PharmaBiz2 months ago

ArQule Presents Preclinical Data for ARQ 531, a Proprietary Reversible Inhibitor of Wild Type and Mutant BTK, at the 2016 Pan Pacific Lymphoma Conference

Data supports further preclinical and clinical research in BTK sensitive and ibrutinib resistant malignancies BURLINGTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq:ARQL) today announced the first public presentation of data on ...
 4 Traders2 months ago
[x]  
Cancer Therapy Advisor

Risk of Arrhythmias, Bleeding Higher With Ibrutinib Therapy

Share this content: Ibrutinib therapy carries a significantly higher risk of atrial fibrillation/flutter and all-grade bleeding compared with other treatments. Ibrutinib therapy carries a significantly higher risk of atrial fibrillation/flutter ...
 Cancer Therapy Advisor2 days ago

Treatment Options for Older Patients With CLL

[embedded content] Steven Coutre, MD: We often treat older patients with ibrutinib. Weve certainly treated them in the context of the trials, and weve treated those patients with commercially available ibrutinib, now that it's approved as ...
 American Journal of Managed Care3 weeks ago Patient Selection for Treatment With Ibrutinib in CLL  American Journal of Managed Care3 weeks ago Determinants of Ibrutinib-induced apoptosis in CLL  Clinical Cancer Research1 month ago Value of Real-World Data in CLL Treatment  American Journal of Managed Care6 days ago

Studies Examine Link Between Ibrutinib and Atrial Fibrillation in Patients With Leukemia and Lymphoma

Though the association between ibrutinib use and atrial fibrillation (AF) has not been statistically validated, the observed incidence of AF among patients taking ibrutinib ranges from 6 to 9 percent. These patients also are at an increased risk for ...
 ASH Clinical News1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Ibrutinib
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less